[ET Net News Agency, 3 June 2025] J.P. Morgan raised the target price for Innovent Bio
(01801) to HKD74 from HKD55 and maintained the "overweight" rating.
The research house said it lifts sales forecast for 29-33E by 7-45%, while keeping
margin assumption largely unchanged. (rc)